RxDoctor Payments Data

Cassandra Piccione

Physician Assistant · Orchard Park, NYNPI 1205110020

Payments from drug & device makers

$697in general payments, 2019–2025

Across 34 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$195
  • Lilly USA, LLC$114
  • Phathom Pharmaceuticals, Inc.$73
  • Merck$68
  • GSK$58
  • Novo Nordisk$42
  • plus $147 from 7 others

What the payments were for

  • Food & beverage$697100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$697 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$14,700
Medicare patients
74
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban25$26,744
Breztri AerosphereBudesonide/Glycopyr/Formoterol38$24,193
FarxigaDapagliflozin Propanediol18$23,266
OzempicSemaglutide24$22,442
TrulicityDulaglutide14$17,296
MounjaroTirzepatide17$17,110
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$14,914
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$11,895
Albuterol Sulfate HfaAlbuterol Sulfate95$3,056
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,284
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$1,874
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$1,513
Levothyroxine Sodium73$1,485
Metoprolol Succinate73$1,326
Lisinopril126$1,311

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$195$47,45956 claims
Lilly USA, LLCTrulicity, Mounjaro$114$34,40631 claims
PfizerEliquis$31$26,74425 claims
Novo NordiskOzempic$42$22,44224 claims
GSKTrelegy Ellipta$58$14,91420 claims
Boehringer IngelheimStiolto Respimat$18$11,89517 claims
AbbVieSynthroid$15$87213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Orchard Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →